Case Study

Process Development For Scaled-up hESC/hiPSC Manufacturing

Source: CCRM
stem cell research female_450x300

Both human embryonic and induced pluripotent stem cells (hESCs and hiPSCs, together PSCs) have the ability to indefinitely self-renew and differentiate into any cell type. Stirred-tank reactors (STRs) for the large-scale expansion of PSCs have been reported by several groups and have the potential to generate clinically relevant amounts of cells. Here we report on a scale-up expansion seed train, able to produce 3.6 x 1010 PSCs in an 8 L volume of a Xcellerex disposable bioreactor.

CHALLENGE
To scale up, close and optimize a suspension-based manufacturing workflow for pluripotent stem cells (PSCs).

PROCESS DEVELOPED
A best-in-class, scalable manufacturing platform with closed passaging and in-line analytics.

OUTCOMES

  • Scalable process capable of >1010 cells per batch
  • 50% process time reduction
  • Development of sample-free and closed workflows
VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: